- Date:
September 2025 - Client:
WellMed B.V. - Sector:
Healthcare - Service:
Partnering advisory
Definitive agreement with Dutch Immunologic (WellMed B.V.) and DAKEWE BIOTECH CO. LTD.
Arnhem, Shenzhen, September 4th, 2025.
Orange Corporate Finance acted as exclusive financial advisor to Dutch Immunologic (WellMed B.V.) to reach the next step in partnering with DAKEWE.
About Immunologic
Immunologic (WellMed B.V.) is a leading Dutch manufacturer and supplier of immunohistochemistry and immunology laboratory products like high-quality reagents, consumables. Immunologic is focusing on immunohistochemistry (IHC), a sensitive diagnostic technique used to study protein expression and gene changes in tissue and cells. Products are sold, marketed and distributed globally, with a strong customer base in hospitals, research institutions, universities, and governmental labs.
The company is based in Arnhem, The Netherlands and is ISO 13485:2016 certified. WellMed is a company under EU Regulation 2017/746.
About DAKEWE
With a strong global presence and over 1.000 dedicated employees at global level, DAKEWE excels in delivering cutting-edge diagnostic reagents, histopathology devices, and life science instruments designed to empower pathology laboratories worldwide. Committed to exceptional quality and continuous innovation, DAKEWE offers a comprehensive portfolio including tissue processors, slide stainers, ELISA kits, and specialized culture media, complemented by unparalleled customer service and technical support.
DAKEWE offers a comprehensive range of immunohistochemistry (IHC) products and services designed to support pathology laboratories and medical research institutions. These antibodies are rigorously validated and tested for consistent, reproducible results in both manual and automated IHC staining processes.
In addition to antibodies, DAKEWE develops advanced IHC instruments, such as the fully automated PathDR.™ NS40R IHC stainer, which efficiently automates the entire staining workflow from baking to counterstaining with high precision and capacity. The company also produces complementary including tissue processors, microtomes, cryostats, slide stainers, and cover slippers that integrate seamlessly to optimize laboratory workflows.
Citaten
Bob van de Woerdt, CEO van WellMed B.V.:
“Wij produceren geavanceerde, state of the art polymeren waarop laboratoria wereldwijd vertrouwen. We zijn dan ook zeer trots dat we onze samenwerking met DAKEWE kunnen aankondigen. Bij WellMed kijken we uit naar een vruchtbare samenwerking.”
Wu Qingjun:
“Met deze definitieve overeenkomst kunnen we ons IHC portfolio wereldwijd uitbreiden naar onze klanten én de klanten van WellMed. Naast het uitbreiden van ons eigen portfolio zetten we ons graag in voor de verdere groei van WellMed.”
